Nukkleus Inc. (NUKK)

Nukkleus Income Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Revenue	5.91	21.3	21.51	19.29	19.2
Revenue Growth (YoY)	-72.23%	-1.00%	11.54%	0.45%	-
Cost of Revenue	4.91	21.64	22.17	19.37	18.9
Gross Profit	1	-0.34	-0.66	-0.08	0.3
Selling, General & Admin	8.63	3.75	5.9	0.85	0.41
Operating Expenses	14.79	5.21	6.17	0.85	0.41
Operating Income	-13.79	-5.55	-6.83	-0.93	-0.11
Interest Expense	-0.55	-0	-	-0	-0.01
Interest & Investment Income	0	0.01	0	-	-
Earnings From Equity Investments	-	-	-0.69	-	-
Other Non Operating Income (Expenses)	0.01	0.02	-0.01	-0	0.02
EBT Excluding Unusual Items	-14.32	-5.51	-7.53	-0.94	-0.1
Asset Writedown	-0.39	-11.91	-4.31	-	-
Other Unusual Items	6.2	-	-	-	-
Pretax Income	-8.52	-17.43	-11.85	-0.94	-0.1
Net Income	-8.52	-17.43	-11.85	-0.94	-0.1
Net Income to Common	-8.52	-17.43	-11.85	-0.94	-0.1
Shares Outstanding (Basic)	2	1	1	32	29
Shares Outstanding (Diluted)	2	1	1	32	29
Shares Change (YoY)	37.23%	3.10%	-96.21%	11.84%	-
EPS (Basic)	-4.93	-13.84	-9.70	-0.03	-0.00
EPS (Diluted)	-4.93	-13.84	-9.70	-0.03	-0.00
Gross Margin	16.89%	-1.61%	-3.07%	-0.43%	1.56%
Operating Margin	-233.14%	-26.05%	-31.75%	-4.83%	-0.59%
Profit Margin	-144.05%	-81.83%	-55.06%	-4.86%	-0.52%
EBITDA	-13.77	-3.17	-4.14	-0.46	-
EBITDA Margin	-232.91%	-14.88%	-19.24%	-2.40%	-
D&A For EBITDA	0.01	2.38	2.69	0.47	-
EBIT	-13.79	-5.55	-6.83	-0.93	-0.11
EBIT Margin	-233.14%	-26.05%	-31.75%	-4.83%	-0.59%
Revenue as Reported	5.91	21.3	21.51	19.29	19.2
Advertising Expenses	0.04	0.06	0.42	0.02	-

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q